CD3 AND ITCR EXPRESSING ENGINEERED NATURAL KILLER CELLS WITH ENHANCED FUNCTION FOR ADOPTIVE IMMUNOTHERAPY

Embodiments of the disclosure include methods and compositions in which NK cells are modified by the hand of man to express the invariant NK T-cell receptor and CD3 co-receptor on NK cells that do not naturally express them. Such modified NK cells work effectively with bispecific or multi-specific a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MARIN COSTA, David, REZVANI, Katy, BASAR, Rafet, LIU, Bin
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MARIN COSTA, David
REZVANI, Katy
BASAR, Rafet
LIU, Bin
description Embodiments of the disclosure include methods and compositions in which NK cells are modified by the hand of man to express the invariant NK T-cell receptor and CD3 co-receptor on NK cells that do not naturally express them. Such modified NK cells work effectively with bispecific or multi-specific antibodies that are tailored to comprise anti-CD3 antibodies that bind the modified NK cells, thereby triggering signaling, activation, and cytotoxicity of target cells to which the antibodies also bind. Thus, the NK cells are specifically configured to be able to work effectively with Bispecific NK cell engagers (BiKEs) as well as Bispecific T cell Engagers (BiTEs). Des modes de réalisation de la divulgation comprennent des méthodes et des compositions dans lesquelles des cellules NK sont modifiées par la main de l'homme pour exprimer le récepteur des lymphocytes T NK et le co-récepteur CD3 sur des cellules NK qui ne les expriment pas naturellement. De telles cellules NK modifiées fonctionnent efficacement avec des anticorps bispécifiques ou multi-spécifiques qui sont adaptés pour comprendre des anticorps anti-CD3 qui se lient aux cellules NK modifiées, ce qui permet de déclencher la signalisation, l'activation et la cytotoxicité de cellules cibles auxquelles les anticorps se lient également. Ainsi, les cellules NK sont spécifiquement conçues pour pouvoir fonctionner efficacement avec des engageurs de cellules NK bispécifiques (BiKE) ainsi que des engageurs de lymphocytes T bispécifiques (BiTE).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2024137789A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2024137789A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2024137789A33</originalsourceid><addsrcrecordid>eNqNyrEKwjAQANAuDqL-w4GzoI1QHUNybQ7TS0lTq1MpEkEQLdT_xw5-gNNb3jx5KC1AsgYKygNeKo91TVwAckGM6FEDy9B4aeFE1qIHhdbW0FIwUzKS1VTyhlUgx5A7D1K7KtAZgcqyYRcMelldl8ns3j_HuPq5SNY5BmU2cXh3cRz6W3zFT9e6dJvudyLLDkcpxH_rCxplNvE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CD3 AND ITCR EXPRESSING ENGINEERED NATURAL KILLER CELLS WITH ENHANCED FUNCTION FOR ADOPTIVE IMMUNOTHERAPY</title><source>esp@cenet</source><creator>MARIN COSTA, David ; REZVANI, Katy ; BASAR, Rafet ; LIU, Bin</creator><creatorcontrib>MARIN COSTA, David ; REZVANI, Katy ; BASAR, Rafet ; LIU, Bin</creatorcontrib><description>Embodiments of the disclosure include methods and compositions in which NK cells are modified by the hand of man to express the invariant NK T-cell receptor and CD3 co-receptor on NK cells that do not naturally express them. Such modified NK cells work effectively with bispecific or multi-specific antibodies that are tailored to comprise anti-CD3 antibodies that bind the modified NK cells, thereby triggering signaling, activation, and cytotoxicity of target cells to which the antibodies also bind. Thus, the NK cells are specifically configured to be able to work effectively with Bispecific NK cell engagers (BiKEs) as well as Bispecific T cell Engagers (BiTEs). Des modes de réalisation de la divulgation comprennent des méthodes et des compositions dans lesquelles des cellules NK sont modifiées par la main de l'homme pour exprimer le récepteur des lymphocytes T NK et le co-récepteur CD3 sur des cellules NK qui ne les expriment pas naturellement. De telles cellules NK modifiées fonctionnent efficacement avec des anticorps bispécifiques ou multi-spécifiques qui sont adaptés pour comprendre des anticorps anti-CD3 qui se lient aux cellules NK modifiées, ce qui permet de déclencher la signalisation, l'activation et la cytotoxicité de cellules cibles auxquelles les anticorps se lient également. Ainsi, les cellules NK sont spécifiquement conçues pour pouvoir fonctionner efficacement avec des engageurs de cellules NK bispécifiques (BiKE) ainsi que des engageurs de lymphocytes T bispécifiques (BiTE).</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240829&amp;DB=EPODOC&amp;CC=WO&amp;NR=2024137789A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240829&amp;DB=EPODOC&amp;CC=WO&amp;NR=2024137789A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MARIN COSTA, David</creatorcontrib><creatorcontrib>REZVANI, Katy</creatorcontrib><creatorcontrib>BASAR, Rafet</creatorcontrib><creatorcontrib>LIU, Bin</creatorcontrib><title>CD3 AND ITCR EXPRESSING ENGINEERED NATURAL KILLER CELLS WITH ENHANCED FUNCTION FOR ADOPTIVE IMMUNOTHERAPY</title><description>Embodiments of the disclosure include methods and compositions in which NK cells are modified by the hand of man to express the invariant NK T-cell receptor and CD3 co-receptor on NK cells that do not naturally express them. Such modified NK cells work effectively with bispecific or multi-specific antibodies that are tailored to comprise anti-CD3 antibodies that bind the modified NK cells, thereby triggering signaling, activation, and cytotoxicity of target cells to which the antibodies also bind. Thus, the NK cells are specifically configured to be able to work effectively with Bispecific NK cell engagers (BiKEs) as well as Bispecific T cell Engagers (BiTEs). Des modes de réalisation de la divulgation comprennent des méthodes et des compositions dans lesquelles des cellules NK sont modifiées par la main de l'homme pour exprimer le récepteur des lymphocytes T NK et le co-récepteur CD3 sur des cellules NK qui ne les expriment pas naturellement. De telles cellules NK modifiées fonctionnent efficacement avec des anticorps bispécifiques ou multi-spécifiques qui sont adaptés pour comprendre des anticorps anti-CD3 qui se lient aux cellules NK modifiées, ce qui permet de déclencher la signalisation, l'activation et la cytotoxicité de cellules cibles auxquelles les anticorps se lient également. Ainsi, les cellules NK sont spécifiquement conçues pour pouvoir fonctionner efficacement avec des engageurs de cellules NK bispécifiques (BiKE) ainsi que des engageurs de lymphocytes T bispécifiques (BiTE).</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQANAuDqL-w4GzoI1QHUNybQ7TS0lTq1MpEkEQLdT_xw5-gNNb3jx5KC1AsgYKygNeKo91TVwAckGM6FEDy9B4aeFE1qIHhdbW0FIwUzKS1VTyhlUgx5A7D1K7KtAZgcqyYRcMelldl8ns3j_HuPq5SNY5BmU2cXh3cRz6W3zFT9e6dJvudyLLDkcpxH_rCxplNvE</recordid><startdate>20240829</startdate><enddate>20240829</enddate><creator>MARIN COSTA, David</creator><creator>REZVANI, Katy</creator><creator>BASAR, Rafet</creator><creator>LIU, Bin</creator><scope>EVB</scope></search><sort><creationdate>20240829</creationdate><title>CD3 AND ITCR EXPRESSING ENGINEERED NATURAL KILLER CELLS WITH ENHANCED FUNCTION FOR ADOPTIVE IMMUNOTHERAPY</title><author>MARIN COSTA, David ; REZVANI, Katy ; BASAR, Rafet ; LIU, Bin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2024137789A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2024</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>MARIN COSTA, David</creatorcontrib><creatorcontrib>REZVANI, Katy</creatorcontrib><creatorcontrib>BASAR, Rafet</creatorcontrib><creatorcontrib>LIU, Bin</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MARIN COSTA, David</au><au>REZVANI, Katy</au><au>BASAR, Rafet</au><au>LIU, Bin</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CD3 AND ITCR EXPRESSING ENGINEERED NATURAL KILLER CELLS WITH ENHANCED FUNCTION FOR ADOPTIVE IMMUNOTHERAPY</title><date>2024-08-29</date><risdate>2024</risdate><abstract>Embodiments of the disclosure include methods and compositions in which NK cells are modified by the hand of man to express the invariant NK T-cell receptor and CD3 co-receptor on NK cells that do not naturally express them. Such modified NK cells work effectively with bispecific or multi-specific antibodies that are tailored to comprise anti-CD3 antibodies that bind the modified NK cells, thereby triggering signaling, activation, and cytotoxicity of target cells to which the antibodies also bind. Thus, the NK cells are specifically configured to be able to work effectively with Bispecific NK cell engagers (BiKEs) as well as Bispecific T cell Engagers (BiTEs). Des modes de réalisation de la divulgation comprennent des méthodes et des compositions dans lesquelles des cellules NK sont modifiées par la main de l'homme pour exprimer le récepteur des lymphocytes T NK et le co-récepteur CD3 sur des cellules NK qui ne les expriment pas naturellement. De telles cellules NK modifiées fonctionnent efficacement avec des anticorps bispécifiques ou multi-spécifiques qui sont adaptés pour comprendre des anticorps anti-CD3 qui se lient aux cellules NK modifiées, ce qui permet de déclencher la signalisation, l'activation et la cytotoxicité de cellules cibles auxquelles les anticorps se lient également. Ainsi, les cellules NK sont spécifiquement conçues pour pouvoir fonctionner efficacement avec des engageurs de cellules NK bispécifiques (BiKE) ainsi que des engageurs de lymphocytes T bispécifiques (BiTE).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2024137789A3
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
title CD3 AND ITCR EXPRESSING ENGINEERED NATURAL KILLER CELLS WITH ENHANCED FUNCTION FOR ADOPTIVE IMMUNOTHERAPY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T19%3A27%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MARIN%20COSTA,%20David&rft.date=2024-08-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2024137789A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true